Table 1.
Source of cells | |||
---|---|---|---|
Cell subpopulation | Age (weeks) | IL-2−/− | IL-2+/+ |
Bone marrow | |||
B220+/IgM− | 8–10† | 1·7 ± 1·1‡ | 4·1 ± 1·6 |
11–13 | 1·3 ± 0·6 | 4·4 ± 0·1 | |
22–26 | 0·5 ± 0·1 | 3·7 ± 0·9 | |
Total cells | 8–10† | 26·5 ± 8·9 | 19·4 ± 6·2 |
11–13 | 35·9 ± 13·2 | 21·8 ± 4·5 | |
22–26 | 10·7 ± 3·9 | 20·2 ± 5·4 | |
Spleen | |||
B220+ | 8–10 | 26·7 ± 11·3 | 57·7 ± 26·5 |
11–13 | 4·3 ± 2·3 | 46·7 ± 18·4 | |
Total cells | 8–10† | 142·6 ± 54·0 | 105·9 ± 49·1 |
11–13 | 110·6 ± 2·3 | 100·0 ± 31·6 |
Bone marrow and spleen cells were collected from IL-2−/− and IL-2+/+ mice between the ages of 8 and 26 weeks. Cell subpopulations were identified by flow cytometry.
Number of mice per group. IL-2−/−: 8–10 weeks, n = 8; 11–13 weeks, n = 3; 22–26 weeks, n = 2. IL-2+/+: 8–10 weeks, n = 7; 11–13 weeks, n = 2; 22–26 weeks, n = 5.
Values represent the mean ± SD of the number of cells(×106) in each subpopulation determined by multiplying the % of bone marrow B220+/IgM− cells (bone marrow gate includes lymphocytes and large granular cells) or splenic B220+ cells (spleen gate includes lymphocytes only) by the total number of cells obtained from bone marrow (femurs) or spleen of each animal.